According to a review by The New York Times, the MFN prices offered on certain drugs through the government’s TrumpRx platform may still be higher than those of other countries. More: TrumpRx's 'world's lowest' drug price claims fall short in
read more
Study to explore mechanism behind novel oral therapy for muscle‑sparing weight loss More: Atrogi begins dosing first subjects in human trial of ATR-258 Source: News
read moreThe once-daily pill stands to shake up the injectable-filled psoriasis market and is in line for blockbuster-level sales. More: J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval Source: fierce
read moreBristol Myers Squibb has added a familiar face to an ongoing initiative to thank oncologists for the valuable time they return to cancer patients’ lives. More: BMS brings ‘Emily in Paris’ star and cancer survivor Ashley Park aboard campaign honoring
read moreSandoz has struck a deal with Samsung Bioepis to commercialize up to five biosimilars, with the first being SB36, a copycat of Takeda’s Entyvio, which is being developed by the South Korea-based biosimilars specialist. More: Sandoz expands biosim collab with
read moreIndiana’s governor Mike Braun aims to create 100,000 “high wage” jobs over the next decade through the plan, with hopes of transforming the state into the “premier destination” for life sciences innovation. More: Indiana homes in on life sciences with
read more© 1994 - 2026 B.M. Pharmaceuticals